Literature DB >> 15618578

Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.

J C Ojoo1, S A Mulrennan, J A Kastelik, A H Morice, A E Redington.   

Abstract

BACKGROUND: It has been proposed that the pH of airway lining fluid may regulate the fractional exhaled concentration of nitric oxide (Fe(NO)) in respiratory disease.
METHODS: Fe(NO), exhaled breath condensate (EBC) pH, and EBC concentrations of nitrite plus nitrate (NO2/NO3) were compared in 12 subjects with stable asthma, 18 with stable cystic fibrosis (CF), and 15 healthy control subjects. Eight of the CF patients were studied on a separate occasion at the start of a pulmonary exacerbation.
RESULTS: Fe(NO) was significantly greater in asthmatic subjects than in control subjects (mean 35 v 9 ppb, p<0.001). EBC pH, however, was similar in the asthmatic and control groups (median 5.82 v 6.08, p=0.23). Levels of NO2/NO3 were on average higher in EBC samples from asthmatic subjects, but the difference was not significant. In patients with stable CF both the Fe(NO) (mean 4 ppb, p<0.001) and EBC pH (median 5.77, p=0.003) were lower than in the control group. Levels of EBC NO2/NO3 (median 29.9 microM; p=0.002) in patients with stable CF, in contrast, were significantly higher than in control subjects. During CF exacerbations, EBC pH was further reduced (median 5.30, p=0.017) but Fe(NO) and NO2/NO3 were unchanged.
CONCLUSIONS: These findings demonstrate a dissociation between EBC pH and Fe(NO) in inflammatory airways disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618578      PMCID: PMC1747154          DOI: 10.1136/thx.2003.017327

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  40 in total

Review 1.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

Authors:  S Kharitonov; K Alving; P J Barnes
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

2.  Condensed expirate nitrite as a home marker for acute asthma.

Authors:  J Hunt; R E Byrns; L J Ignarro; B Gaston
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

3.  Increased levels of nitric oxide derivatives in induced sputum in patients with asthma.

Authors:  H Kanazawa; S Shoji; M Yamada; T Fujii; T Kawaguchi; S Kudoh; K Hirata; J Yoshikawa
Journal:  J Allergy Clin Immunol       Date:  1997-05       Impact factor: 10.793

4.  Exhaled nitric oxide in paediatric asthma and cystic fibrosis.

Authors:  J O Lundberg; S L Nordvall; E Weitzberg; H Kollberg; K Alving
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

5.  Airway nitric oxide in asthmatic children and patients with cystic fibrosis.

Authors:  J Dötsch; S Demirakça; H G Terbrack; G Hüls; W Rascher; P G Kühl
Journal:  Eur Respir J       Date:  1996-12       Impact factor: 16.671

6.  Reduced upper airway nitric oxide in cystic fibrosis.

Authors:  I M Balfour-Lynn; A Laverty; R Dinwiddie
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

7.  Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis.

Authors:  H Grasemann; E Michler; M Wallot; F Ratjen
Journal:  Pediatr Pulmonol       Date:  1997-09

8.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.

Authors:  J V Fahy; K W Kim; J Liu; H A Boushey
Journal:  J Allergy Clin Immunol       Date:  1995-04       Impact factor: 10.793

9.  Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.

Authors:  D H Yates; S A Kharitonov; R A Robbins; P S Thomas; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

10.  Expired nitric oxide levels during treatment of acute asthma.

Authors:  A F Massaro; B Gaston; D Kita; C Fanta; J S Stamler; J M Drazen
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

View more
  36 in total

1.  Function of Proton Channels in Lung Epithelia.

Authors:  Horst Fischer
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2011-10-25

Review 2.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

3.  Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis.

Authors:  Vladimír Rihák; Petr Zatloukal; Jirina Chládková; Alena Zimulová; Zuzana Havlínová; Jaroslav Chládek
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

5.  Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.

Authors:  Xiaoling Zang; José J Pérez; Christina M Jones; María Eugenia Monge; Nael A McCarty; Arlene A Stecenko; Facundo M Fernández
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-31       Impact factor: 3.109

6.  Exhaled breath condensate pH in patients with cystic fibrosis.

Authors:  Balazs Antus; Imre Barta; Eszter Csiszer; Krisztina Kelemen
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

7.  Magnesium and calcium in exhaled breath condensate of children with asthma and gastroesophageal reflux disease.

Authors:  Slavica Dodig; Zeljka Vlasić; Ivana Cepelak; Renata Zrinski Topić; Mirjana Turkalj; Boro Nogalo
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 8.  Mechanisms and function of DUOX in epithelia of the lung.

Authors:  Horst Fischer
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

9.  Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients.

Authors:  Rembert Koczulla; Silvano Dragonieri; Robert Schot; Robert Bals; Stefanie A Gauw; Claus Vogelmeier; Klaus F Rabe; Peter J Sterk; Pieter S Hiemstra
Journal:  Respir Res       Date:  2009-08-24

10.  Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough.

Authors:  Amina Hamed Ahmad Al Obaidi
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.